SGLT2 Inhibitor Effects on Inflammation and Heart Disease in Obesity Pilot
Clinical trial NCT04907214 · COMPLETED
Trial details
- NCT number
- NCT04907214
- Sponsor
- Vanderbilt University Medical Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-29
- Primary completion
- 2023-12-08
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.